WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Apollo inks €3B equity deal for stake in Bayer's contraceptives business

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal

Raccontata daeconomictimes.indiatimes.commanager-magazin.defiercepharma.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
fiercepharma.comStai leggendo5 h fa

Apollo inks €3B equity deal for stake in Bayer's contraceptives business

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal

originale
economictimes.indiatimes.com13 h fa

Bayer gets €3 billion in Apollo deal for contraceptives unit

Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible contraceptives business. Apollo funds will take a minority stake while Bayer retains control. The…

Leggi questa versione → originale
manager-magazin.de12 h fa

Bayer: Apollo-Deal über 3 Milliarden Euro verschafft finanziellen Spielraum

Für die jahrelangen Glyphosat-Rechtsstreitigkeiten hat Bayer Milliarden ausgegeben und sich hoch verschuldet. Jetzt steigt Apollo bei einem Subunternehmen für Verhütungsmittel ein und verschafft Bayers CFO Judith…

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 10 luglio 2026·economictimes.indiatimes.com

    Bayer gets €3 billion in Apollo deal for contraceptives unit

    Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible contraceptives business. Apollo funds will take a minority…

  2. venerdì 10 luglio 2026·manager-magazin.de

    Bayer: Apollo-Deal über 3 Milliarden Euro verschafft finanziellen Spielraum

    Für die jahrelangen Glyphosat-Rechtsstreitigkeiten hat Bayer Milliarden ausgegeben und sich hoch verschuldet. Jetzt steigt Apollo bei einem Subunternehmen für Verhütungsmittel ein…

  3. venerdì 10 luglio 2026·fiercepharma.com

    Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials

    In the two weeks before and after Independence Day in the U.S., AstraZeneca signed potential billion-dollar licensing deals with CSPC Pharmaceutical and Sino Biopharmaceutical,…

  4. venerdì 10 luglio 2026·fiercepharma.com

    Apollo inks €3B equity deal for stake in Bayer's contraceptives business

    Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal